439P Phase Ib/II Study of Ibrutinib (ibr) in Combination with Cetuximab (cetux) in Patients (pts) with Previously Treated Metastatic Colorectal Cancer (Mcrc)
ANNALS OF ONCOLOGY（2020）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined